Dipartimento di Laboratorio, Servizio Trasfusionale, Centro per le Malattie del Sangue e Presidio Regionale Malattie rare per le Coagulopatie Congenite, Castelfranco Veneto Hospital (TV), Castelfranco Veneto, Italy.
Haemophilia. 2013 Nov;19(6):898-903. doi: 10.1111/hae.12219. Epub 2013 Jun 28.
This article describes prenatal diagnosis (PND) of haemophilia B (HB) within the framework of Italian haemophilia centres and genetics laboratories. The study details the experience from six haemophilia genetic centres (three in the North, one in the Centre and two in the South of Italy) and summarizes the different techniques used to perform PND of HB during the last 15 years. To date, the Italian HB database includes 373 characterized unrelated patients and their genetic information has permitted the identification of 274 carriers of childbearing age. This database represents the main instrument for timely and precise PND. Sixty-six prenatal diagnoses were performed on 52 HB carriers whose average age at the time was 34 (ranging from 24 to 44 years). In 44 cases, genetic counselling for carrier status determination was performed before pregnancy, while eight were not studied prior to pregnancy. Foetal samples were obtained by chorionic villus sampling in 52 cases, by amniocentesis in 12 while two were diagnosed by analysis of free foetal DNA obtained from maternal peripheral blood. In 35 (53%) pregnancies the foetus was female. For 31 men (47%), haemophilia status was determined by analysis of previously determined informative markers or familial mutations (12 affected and 19 unaffected). There may be more than one laboratory involved in the PND diagnostic pathway (providing DNA extraction, karyotype analysis, gender determination, maternal contamination detection, molecular diagnosis and sequencing). Good communication between all the parties, coordinated by the haemophilia centre, is essential for a successful and rapid process.
本文描述了意大利血友病中心和遗传实验室框架内的乙型血友病(HB)产前诊断(PND)。该研究详细介绍了来自六个血友病遗传中心(意大利北部三个、中部一个和南部两个)的经验,并总结了过去 15 年来用于 HB PND 的不同技术。迄今为止,意大利 HB 数据库包括 373 名特征明确的无关患者,其遗传信息已确定了 274 名育龄携带者。该数据库是及时、准确进行 PND 的主要工具。对 52 名 HB 携带者的 66 例产前诊断进行了分析,这些携带者的平均年龄为 34 岁(24-44 岁)。在 44 例中,在怀孕前进行了携带者状态确定的遗传咨询,而在 8 例中,怀孕前未进行研究。通过绒毛膜绒毛取样获得了 52 例胎儿样本,通过羊膜穿刺术获得了 12 例,而通过分析从母亲外周血中获得的游离胎儿 DNA 诊断了 2 例。在 35 例(53%)妊娠中,胎儿为女性。对于 31 名男性(47%),通过分析先前确定的信息标记物或家族突变来确定血友病状态(12 例为受影响者,19 例为未受影响者)。在 PND 诊断途径中可能涉及多个实验室(提供 DNA 提取、核型分析、性别确定、母体污染检测、分子诊断和测序)。由血友病中心协调,所有各方之间的良好沟通对于成功和快速的过程至关重要。